Navigation Links
Akela Pharma provides corporate update
Date:12/20/2007

http://www.akelapharma.com Toronto Stock Exchange Symbol: AKL

MONTREAL, Dec. 20 /PRNewswire-FirstCall/ - Akela Pharma Inc. (TSX: "AKL"), a drug development company focused on developing therapies for the inhalation and pain markets, today announced that due to unfavorable market conditions, particularly in the small and micro-cap sector, it has decided to abandon its US public offering initiative. The Company is currently contemplating other financing options. It is still the Company's intention to list its shares on a US exchange.

Akela also announces it has already started to implement significant cost reduction measures to bring its cash burn rate in line with its current and expected financial resources. The Company will primarily focus its R&D activities on its core programs. PharmaForm, the Company's drug formulation and manufacturing subsidiary located in Austin, Texas, is currently experiencing substantial growth, and is expected to contribute towards the Company's operating cash flow in the near term.

"Although the latest unfavorable market conditions did not allow us to complete our US public offering as originally planned, we remain extremely confident about the appeal and commercial potential of our products and platforms. We have aligned our corporate focus with our financial resources to ensure optimal returns on our core activities" said Dr Halvor Jaeger, CEO of Akela Pharma Inc.

About Akela Pharma Inc.

Akela Pharma is an integrated drug development company focused on developing therapies for the growing multi-billion dollar inhalation and pain markets. Its lead product, for the treatment of breakthrough cancer pain, is a fast-acting Fentanyl formulation delivered using the Company's TAIFUN(R) dry powder inhaler platform. Its pipeline also includes therapeutics for asthma, COPD, growth hormone deficiencies and controlled substance abuse deterrent fo
'/>"/>

SOURCE AKELA PHARMA INC.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
2. Akela Pharma Inc. Completes Share Consolidation
3. AKELA Pharma Inc. announces U.S. public offering and proposed listing
4. Akela Pharma reports results for third quarter of fiscal 2007
5. Akela Pharma announces final positive results from its growth hormone releasing hormone (GHRH) Phase II trial
6. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
7. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
8. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
9. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
10. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
11. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...D, Calif., Dec. 4 Herpes zoster, a... who have been vaccinated against chicken pox, acc...r issue of the Pediatric Infectious Diseases Jour...ed electronic health records to identify more than...hicken pox) vaccine from 2002 to 2008 in Kaiser Pe...
(Date:12/3/2009)... Chiropractic Traffic has gotten into the ho...opular marketing tool. $1 gets chiropractors 3 mon...ropractic Traffic is even including chiropractic p... (PRWEB) December 3, 2009 -- Chiroprac...arketing tool. Chiropractic Marketing expertise p...
(Date:12/3/2009)...GTON, Dec. 3 Family Re...oday to the U.S. Senate,s approval of an amendment...authorize the Health Resources and Services Admini... care" in their guidelines. If HRSA decides to inc...d individual health plans will be required by law ...
(Date:12/3/2009)...BORO, N.J., Dec. 3 The development...nsboro (UMCPP) reached a milestone today with a "t...eel-frame construction at the new hospital that wi...(UMCP). ,, (Photo: http://www.newscom.com/cgi-...remony is a steelworkers, tradition in which a ste...
(Date:12/3/2009)...SHINGTON, Dec. 3 Today ... to the Senate health care bill by a vote of 61-39...ion coverage, but it also fails to explicitly exc...istration (HRSA) could categorize abortion as "pre...age for abortion by all private plans. The recomm...
Breaking Medicine News(10 mins):Health News:Chicken Pox Vaccine May Also Reduce Risk of Shingles Among Children 2Health News:Chicken Pox Vaccine May Also Reduce Risk of Shingles Among Children 3Health News:New Chiropractic Marketing: A $1 Chiropractic Marketing Tool that Can Make Users $1000s 2Health News:Senate Approval of Mikulski Amendment Further Opens Health Care Bill to Massive Federal Funding of Abortion 2Health News:'Topping Out' Ceremony Marks Milestone in Construction of University Medical Center of Princeton at Plainsboro 2Health News:'Topping Out' Ceremony Marks Milestone in Construction of University Medical Center of Princeton at Plainsboro 3Health News:'Topping Out' Ceremony Marks Milestone in Construction of University Medical Center of Princeton at Plainsboro 4Health News:Americans United For Life: Senate Passes the Pro-Abortion Mikulski Amendment Under the Guise of 'Preventive Care' 2
...11 Washington state nursing,leader Sally Watkins,...rsing Practice, Education, and Research by the Was...,s oldest and largest professional nurses,associat...utive,Director Judy Huntington, MN, RN. "We are ex...
...d unpredictable lifestyles are significant factors...come HIV-positive people, a new UCLA study has fou...r issue of the Journal of General Internal Medicin...arrier to regular medical care. The researchers al...
...improvement with carvedilol , , TUESDAY, S...mber of the beta blocker drug family that has been...help children with the condition, a new study foun... youngsters who got a placebo. , "Heart failure in...
... tailored virus destroys brain tumor stem cells th...th of cancer after surgery, a research team led by...son Cancer Center reports in the Sept. 18 edition ...that we have a tool that can target and eliminate ...
...stionnaire developed at the University of Oregon a...time before or after a doctors appointment is cred...ear-old and 2-year-old children with mild developm...ring would not have been made without the Ages & S...
...inds a similar drug, Actos, may be a better choice...ealthDay News) -- A controversial drug called Avan...d sugar, greatly increases their risk of heart att...and benefits has shifted, and this needs to be fac...
Other Medicine News:Health News:New Director of Nursing Practice Named for Nurses Association 2Health News:Personal chaos in HIV patients' lives may be a barrier to regular medical care, UCLA Study Shows 2Health News:Beta Blocker Doesn't Help Children With Heart Failure 2Health News:Customized virus kills brain tumor stem cells that drive lethal cancer 2Health News:Customized virus kills brain tumor stem cells that drive lethal cancer 3Health News:Customized virus kills brain tumor stem cells that drive lethal cancer 4Health News:Parental surveys boost diagnosis abilities of pediatricians 2Health News:Parental surveys boost diagnosis abilities of pediatricians 3Health News:Diabetes Drug Avandia Boosts Heart Risks: Study 2Health News:Diabetes Drug Avandia Boosts Heart Risks: Study 3
(Date:12/3/2009)...URHAM, N.C., Dec. 3 In ...thcare information technologies in the evolving he...d the Duke Center for Health Informatics (DCHI) to...HI will oversee an innovative interdisciplinary ap...tion of physicians, nurses and healthcare administ...
(Date:12/3/2009)... NEW YORK, Dec. 3 Alzheimer,s dise...s a person can receive. This irreversible, progres...king skills and eventually even the ability to car...f dementia among older people, AD affects as many ... to the National Institute on Aging. ,, (Logo:...
(Date:12/3/2009)...LAMAZOO, Mich., Dec. 3 S...that its Board of Directors has authorized the Com...n stock. The manner, timing and amount of any pur...ent based on their evaluation of market conditions...t to regulatory considerations. Purchases may be ...
Breaking Medicine Technology:Duke Medicine to Train Healthcare Professionals in Health Informatics 2Duke Medicine to Train Healthcare Professionals in Health Informatics 3Alzheimer's Research May Lead to Preventing the Debilitating Disease 2Alzheimer's Research May Lead to Preventing the Debilitating Disease 3Stryker Announces $750 Million Share Repurchase Program and Declares a $0.15 Per Share Quarterly Dividend 2Women More Likely Than Men to Reject Unattractive Babies 49890 1Women More Likely Than Men to Reject Unattractive Babies 49890 2Maui Jim Teams With Unite for Sight in New Buy One Give One Program to Improve Eye Health Amongst the Worlds Most Needy 49888 1Maui Jim Teams With Unite for Sight in New Buy One Give One Program to Improve Eye Health Amongst the Worlds Most Needy 49888 2Maui Jim Teams With Unite for Sight in New Buy One Give One Program to Improve Eye Health Amongst the Worlds Most Needy 49888 3TrinityCare Senior Living Announces Funding Agreement for Fourth Senior Living Facility 49886 1TrinityCare Senior Living Announces Funding Agreement for Fourth Senior Living Facility 49886 2
...nalyses of secondary endpoints of a long-term safe..., Nasdaq: SHPGY, TSX: SHQ) ulcerative colitis,(UC)... on LIALDA in,patients with mild to moderate ulcer...l, a long-term, Phase III, open-label 12-14 month,...The American College of,Gastroenterology (ACG) mee...
...alized,patients with schizophrenia showed signific...) (paliperidone) Extended-Release Tablets as compa...mptom improvement was,observed with INVEGA as earl...the end of the two-week study period, according to...al U.S. Psychiatric and Mental Health,Congress in ...
Other Medicine Technology:New Analyses of Long-Term LIALDA(TM) (mesalamine) Data Presented at ACG 2New Analyses of Long-Term LIALDA(TM) (mesalamine) Data Presented at ACG 3New Analyses of Long-Term LIALDA(TM) (mesalamine) Data Presented at ACG 4New Analyses of Long-Term LIALDA(TM) (mesalamine) Data Presented at ACG 5New Analyses of Long-Term LIALDA(TM) (mesalamine) Data Presented at ACG 6New Analyses of Long-Term LIALDA(TM) (mesalamine) Data Presented at ACG 7INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients 2INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients 3INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients 4INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients 5INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients 6INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients 7
...e analyzer that ensures accurate results, test aft...ing "hands on" operator time. And its convenient, ...s large or small., ,The Chemstrip Criterion I...ssing of Chemstrip 10 MD Urine Test Strips from Ro...
Integra Epilepsy Epidural Peg Electrodes and Accessories
Integra Epilepsy Strip Electrodes
...n R. Gates and Mary E. Dunn at the Minnesota Epile...reliability, safety and ease of use. For cortical ...ounted flush with the electrode surface, are indiv...and depth electrodes are fitted with a gold plated...
Medicine Products: